QuantiFERON-TB GOLD— An Innovation in Tuberculosis Screening

Cellestis. (2005). QFTGOLD Fact Sheet. Retrieved March 8, 2006, from www.cellestis.com/IRM/content/home/QFTGOLDFactSheet.pdf.

Centers for Disease Control and Prevention. (2002). Tuberculosis morbidity among U.S.-born and foreign-born populations: United States, 2000. Morbidity and Mortality Weekly Report, 51(5), 101–104.

Centers for Disease Control and Prevention. (2003). Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Morbidity and Mortality Weekly Report, 52(RR-2), 15–18.

Centers for Disease Control and Prevention. (2005). Tuberculosis facts. Retrieved from www.cdc.gov/nchstp/tb/faqs/qa_introduction.htm.

Ferrara G. Losi M. Meacci M. Meccugni B. Piro R. Roversi P. (2005). Routine hospital use of a new commercial whole blood interferon-γ assay for the diagnosis of tuberculosis infection. American Journal of Respiratory and Critical Care Medicine, 172(5), 631–635.

Kang Y. Lee H. W. Yoon H. I. Cho B. Han S. K. Shim Y. S. (2005). Discrepancy between the tuberculin skin test and the whole-blood interferon-γ assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. Journal of the American Medical Association, 293(22), 2756–2761.

Mori T. Sakatani M. Yamagishi F. Takashima T. Kawabe Y. Nagao K. (2004). Specific detection of tuberculosis infection. American Journal of Respiratory and Critical Care Medicine, 170(1), 59–64.

World Health Organization. (2001). Tuberculosis facts. Retrieved October 2, 2003, from http://w3.whosea.org/tb/basic.htm.